Suppr超能文献

伴放线放线杆菌与破坏性牙周病。三年随访结果。

Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results.

作者信息

Buchmann R, Müller R F, Heinecke A, Lange D E

机构信息

Department of Periodontology, School of Dental Medicine, University of Münster, Germany.

出版信息

J Periodontol. 2000 Mar;71(3):444-53. doi: 10.1902/jop.2000.71.3.444.

Abstract

BACKGROUND

Convincing data exist that A. actinomycetemcomitans is an etiologic agent of periodontal disease. The purpose of this longitudinal study was to evaluate A. actinomycetemcomitans as a diagnostic indicator for periodontal disease in treated and periodontally maintained patients.

METHODS

Following comprehensive mechanical/surgical and supportive amoxicillin plus metronidazole therapy in 13 subjects with A. actinomycetemcomitans-associated destructive periodontal disease, we monitored subgingival A. actinomycetemcomitans at 4 individual sites in each patient up to 3 years post-therapy. The periodontal status was determined, and A. actinomycetemcomitans levels were quantitatively enumerated on TSBV agar in CFU/ml. Six patients with a persistence of subgingival A. actinomycetemcomitans at each reexamination within 3 years post-therapy were selected to be at risk for minor periodontal treatment outcomes and further recurrence of periodontal disease (test group). Seven subjects with a complete suppression of A. actinomycetemcomitans at each post-therapy visit served as controls.

RESULTS

The periodontal parameters decreased from overall values of 6.39 mm (probing depth, PD) and 7.64 mm (clinical attachment level, CAL) at the outset to 3.81 mm (PD) and 5.62 mm (CAL) 2 years post-therapy (Friedman, P< or =0.05). At the 3-year reexamination, the PD/CAL scores increased to 4.03/5.78 mm. Among the 6 individuals (46%) with persistence of subgingival A. actinomycetemcomitans at the final 3-year visit (test group), periodontal status yielded increased levels of 4.45 mm (PD) and 6.60 mm (CAL). The control subjects (n = 7) revealed lower values of 3.67 mm (PD) and 5.09 mm (CAL). However, on a patient level, during the 3-year observational trial, the periodontal status of the 13 individuals was not statistically affected by subgingival infection with A. actinomycetemcomitans.

CONCLUSIONS

Although in advanced periodontal disease, comprehensive mechanical and antimicrobial treatment is an appropriate regimen for sustained improvement of periodontal health, long-term control of subgingival infection with A. actinomycetemcomitans could not be achieved. In the maintenance care of destructive periodontitis, the persistence of A. actinomycetemcomitans is not a diagnostic parameter for periodontal disease.

摘要

背景

有确凿数据表明伴放线放线杆菌是牙周疾病的病原体。这项纵向研究的目的是评估伴放线放线杆菌作为接受治疗并维持牙周健康患者牙周疾病诊断指标的价值。

方法

对13例伴放线放线杆菌相关性破坏性牙周疾病患者进行全面的机械/外科治疗及辅助性阿莫西林加甲硝唑治疗后,我们在每位患者的4个独立位点监测龈下伴放线放线杆菌,直至治疗后3年。确定牙周状况,并在胰蛋白胨大豆血琼脂培养基上以CFU/ml定量计数伴放线放线杆菌水平。选择6例在治疗后3年内每次复查时龈下伴放线放线杆菌持续存在的患者,其存在牙周治疗效果不佳及牙周疾病进一步复发的风险(试验组)。7例在每次治疗后复诊时伴放线放线杆菌完全被抑制的受试者作为对照组。

结果

牙周参数从初始时的探诊深度(PD)总体值6.39 mm和临床附着水平(CAL)7.64 mm降至治疗后2年的3.81 mm(PD)和5.62 mm(CAL)(Friedman检验,P≤0.05)。在3年复查时,PD/CAL评分增至4.03/5.78 mm。在最终3年复诊时,6例(46%)龈下伴放线放线杆菌持续存在的个体(试验组)的牙周状况显示PD为4.45 mm、CAL为6.60 mm,水平升高。对照组(n = 7)的值较低,PD为3.67 mm、CAL为5.09 mm。然而,在个体水平上,在3年观察期内,13例个体的牙周状况未受到龈下伴放线放线杆菌感染的统计学影响。

结论

虽然在晚期牙周疾病中,全面的机械和抗菌治疗是持续改善牙周健康的合适方案,但无法实现对龈下伴放线放线杆菌感染的长期控制。在破坏性牙周炎的维持治疗中,伴放线放线杆菌的持续存在不是牙周疾病的诊断参数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验